Intra-Cellular Therapies Inc (NAS:ITCI)
$ 83.4 -0.48 (-0.57%) Market Cap: 8.84 Bil Enterprise Value: 7.90 Bil PE Ratio: 0 PB Ratio: 7.72 GF Score: 61/100

Q4 2022 Intra-Cellular Therapies Inc Earnings Call Transcript

Mar 01, 2023 / 01:30PM GMT
Release Date Price: $49.32 (+0.59%)
Operator

Thank you for standing by, and welcome to the Intra-Cellular Therapeutics Fourth Quarter 2022 Earnings Conference Call. (Operator Instructions)

And now I'd like to introduce your host for today's program, Dr. Juan Sanchez, Vice President, Corporate Communications and Investor Relations. Please go ahead.

Juan Fernando Sanchez
Intra-Cellular Therapies, Inc. - VP of Corporate Communications & IR

Good morning, and thank you all for joining us on our fourth quarter and full-year 2022 earnings call. Joining me on the call today are Dr. Sharon Mates, Chairman and Chief Executive Officer; Mark Newmann, Chief Commercial Officer; Dr. Suresh Dargan, Chief Medical Officer; and Larry Hineline, Chief Financial Officer.

As a reminder, during today's call, we will be making certain forward-looking statements. These forward-looking statements are based on current information, assumptions and expectations. Those are subject to change and involve a number of risks and uncertainties that may cause actual results to differ materially from those contained in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot